Avantor® reports fourth quarter and full year 2023 results

Fourth quarter 2023 net sales of $1.72 billion, decrease of 4.0%; core organic decline of 4.8% net income of $98.5 million; adjusted ebitda of $302.1 million diluted gaap eps of $0.15; adjusted eps of $0.25 operating cash flow of $251.6 million; free cash flow of $201.0 million full year 2023 net sales of $6.97 billion, decrease of 7.3%; core organic decline of 5.2% net income of $321.1 million; adjusted ebitda of $1,309.1 million diluted gaap eps of $0.47; adjusted eps of $1.06 operating cash flow of $870.0 million; free cash flow of $723.6 million adjusted net leverage of 3.9x; repaid approximately $850 million of debt in 2023 radnor, pa. , feb. 14, 2024 /prnewswire/ -- avantor, inc. (nyse: avtr), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for the fourth quarter and year ended december 31, 2023.
AVTR Ratings Summary
AVTR Quant Ranking